Zusammenfassung
Das Makulaödem wurde bereits Ende des 19. Jahrhunderts als Krankheitsbild beschrieben. Ursächlich kommen überwiegend vaskuläre, entzündliche, degenerative und kongenitale Erkrankungen oder Traumata in Frage. Mit zunehmender Kenntnis über die Pathogenese des Makulaödems haben sich auch die Therapieansätze im Laufe der Zeit gewandelt. Sie umfassen neben der Laserbehandlung oder der medikamentösen Therapie auch die chirurgische Intervention. Die Pars-plana-Vitrektomie (evtl. mit ILM-Peeling) scheint vor allem bei bestimmten Formen des Makulaödems, die mit Pathologien des Glaskörpers bzw. der vitreoretinalen Grenzfläche einhergehen, erfolgversprechend. Zur Behandlung therapieresistenter Formen des Makulaödems gewinnt auch die intravitreale Medikamentenapplikation, z. B. von Triamcinolon, an Bedeutung.
Abstract
At the end of the nineteenth century, “macular edema” had already been recognized as a pathological condition. The main causes for macular edema are vascular, inflammatory, degenerative, and congenital diseases or trauma. The therapeutic approaches have changed along with the increasing knowledge on the underlying causes of action during the last few years and include laser treatment as well as surgical interventions. Pars plana vitrectomy (including ILM peeling) seems beneficial in cases of macular edema that are associated with alterations of the vitreous or the vitreoretinal interface. For the treatment of chronic macular edema, intravitreal application of agents such as triamcinolone has become an option.
Literatur
Aiello LP, Bursell SE, Clermont A et al. (1997) Diabetes 46:1473–1480
Antonetti DA, Barber AJ, Khin S et al. (1998) Vascular permeability in experimental diabetes associated with reduced endothelial occludin content. Diabetes 47:1953–1959
Bangerter A (1945) Zur Diagnose, Differentialdiagnose und Therapie des cystoiden Makulaödems (Maculacysten). Ophthalmologica 109:102–122
Benhamou N, Massin P, Haouchine B et al. (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135:246–249
Boniuk M (1968) Cystic macular edema secondary to vitreoretinal traction. Surv Ophthalmol 13:118–121
Bresnik GH (1983) Diabetic maculopathy. A clinical review highlighting diffuse macular edema. Ophthalmology 90:1301–1317
Brooks HL (2000) Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107:139–149
Capone A, Panozzo G (2000) Vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 15:78–80
De Bustros S, Rice TA, Michels RG et al. (1988) Vitrectomy for macular pucker after treatment of retinal tears or retinal detachment. Arch Ophthalmol 106:758–750
Dugel PU, Rao NA, Ozler S, Ligget PE, Smith RE (1992) Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology 99:1535–1541
Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Eearly Treatment diabetic Retinopathy Study Report No. 1. Arch Ophthalmol 103:1796–1806
Ferrari TM, Cardascia N, Durante G (1999) Pars plana vitrectomy in diabetic macular edema. Doc Ophthalmol 97:267–270
Gandorfer A, Haritoglou C, Kampik A (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44:316–323
Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A (2001) Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 132:431–433
Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2001) Indocyanine Green Selectively Stains the Internal Limiting Membrane. Am J Ophthalmol 131:387–388
Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126–133
Gaudric A, Cohen D (1992) Chirurgie des membranes epimaculaires idiopathiques. Facteurs prognostiques. J Fr Ophtalmol 15:657–668
Graefe von A (1858) Ueber die mit Diabetes mellitus vorkommenden Sehstörungen. Dies Arch IV 2:230–234
Harbour JW, Smiddy WE, Flynn HW, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413
Haritoglou C, Ehrt O, Gass CA, Kristin N, Kampik A (2001) Paracentral scotomata: A new finding after vitrectomy for idiopathic macular hole. Br J Ophthalmol 85:231–233
Haritoglou C, Gandorfer A, Gass CA et al. (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: A clinicopathologic correlation. Am J Ophthalmol 134:836–841
Haritoglou C, Gandorfer A, Gass CA (2003) The effect of Indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 135:328–337
Haritoglou C, Gass CA, Gandorfer A, Kampik A (2002) ICG-assited peeling of the retinal ILM. Ophthalmology 106:1039
Haritoglou C, Gass CA, Schaumberger M (2001) Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 132:363–369
Heiligenhaus A, Bornfeld N, Wessing A (1996) Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol 7:77–79
Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478
Hikichi T, Trempe CL (1993) Role of the vitreous in the prognosis of peripheral uveitis. Am J Ophthalmol 116:401–405
Irvine SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36:599–619
Jaeger E (1856) Beiträge zur Pathologie des Auges. Wien, S 33
Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:782–783
Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61
Jonas JB, Sofker A (2001) Intraocular injection of cristalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425–427
Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S (2000) Staining of the internal limiting membrane in macular hole surgery. Arch Ophthalmol 118:1116–1118
Kaiser PK, Riemann CD, Sears JE, Lewis H (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131:44–49
Kampik A, Green WR, Michels RG, Nase PK (1980) Ultrastructural features of progressive epiretinal membranes removed by vitreous surgery. Am J Ophthalmol 90:797–809
Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC (1981) Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 99:1445–1454
Kiryu J, Kita M, Tanabe T (2001) Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology108:1140–1144
Koerner F, Garweg J (1999) Vitrectomy for macular pucker and vitreomacular traction syndrome. Doc Ophthalmol 97:245–254
La Heij EC, Hebdrikse F, Kessels AGH, Derhaag PJFM (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239:264–270
Lewis H, Abrams GW, Blumenkranz MS, Campo R (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753–759
Lewis H (2001) The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 131:123–125
Machemer R (1978) Die chirurgische Entfernung von epiretinalen Makula-Membranen (macular pucker). Klin Monatsbl Augenheilkd 172:36–42
Martidis A, Duker JS, Greenberg PB et al. (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927
McDonald HR, Johnson RN, Schatz H (1994) Surgical results in the vitreomacular traction syndrome. Ophthalmology 101:1397–1402
Messmer EM, Heidenkummer HP, Kampik A (1998) Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 236:248–254
Michels RG (1981) Vitreous surgery for macular pucker. Am J Ophthalmol 92:628–639
Mitchell P, Smith W, Chey T, Wang JJ, Chang A (1997) Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 104:1033–1040
Nasrallah FP, Jalkh AE, VanCoppenrolle F et al. (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339
Nettleship E (1872) On oedema or cystic disease of the retina. Ophth Hosp Rep 7:343–351
Noyes HD (1869) Retinitis in glycosuria. Trans Am Ophthalmol Soc 4:71–75
Pendergast SD, Hassan TS, Williams GA et al. (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130:178–186
Pournaras CJ, Kapetanios AD, Donati G (1999) Vitrectomy for traction macular edema. Doc Ophthalmol 97:235–243
Rice TA, de Bustros S, Michels RG (1986) Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology 93:602–610
Sander B, Larsen M, Maldow B, Lund-Andersen H (2001) Diabetic macular edema : passive and active transport of fluorescein through the blood-retinal barrier. Invest Ophthalmol Vis Sci 42:433–438
Sato Y, Lee Z, Shimada H (2001) Vitrectomy for diabetic cystoid macular edema. Nippon Ganka Gakkai Zasshi 105:251–256
Smiddy EW, Green WR, Michels GR, de la Cruz Z (1989) Ultrastructural studies of vitreomacular syndrome. Am J Ophthalmol 107:177–185
Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289
Tachi N, Ogina N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260
Verbraeken H (1996) Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results. Graefes Arch Clin Exp Ophthalmol 234:288–293
Vogt A (1918) Weitere Ophthalmoskopische Beobachtungen im rotfreien Licht: Cystische Degeneration der Makula lutea. Klin Monatsbl Augenheilkd 61:379–392
Weinberger D, Fink-Cohen S, Gaton et al. (1995) Non-retinovascular leakage in diabetic retinaopathy. Br J Ophthalmol 79:728–731
Wiechens B, Nolle B, Reichelt JA (2001) Pars-plane vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol 239:474–481
Yamamoto T, Naoko A, Takeuchi S (2001) Vitrectomy for diabetic macular edema: The role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 132:369–377
Yang CM (2000) Surgical treatment for severe macular edema with massive hard exsudates. Retina 20:121–125
Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolon for cystoid macular edema in uveitis. Clin Experiment Ophthalmol 29:2–6
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haritoglou, C., Kampik, A. Die Chirurgie des Makulaödems. Ophthalmologe 101, 618–625 (2004). https://doi.org/10.1007/s00347-004-1027-z
Issue Date:
DOI: https://doi.org/10.1007/s00347-004-1027-z